medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2019, Number 2

<< Back

Rev Latin Infect Pediatr 2019; 32 (2)

Osteomyelitis of the fourth metacarpal by Bacillus cereus in a pediatric patient

Fortes GS, González-Saldaña N, Castillo-Bejarano JI, Ortiz CMI, Ordoñez OJ

Language: Spanish
References: 13
Page: 78-80
PDF size: 114.97 Kb.


ABSTRACT

Bacillus spp. has more than 100 different species distributed ubiquitously in the environment. The Bacillus cereus group includes seven closely related species. The medically relevant group consists of Bacillus anthracis, B. cereus, B. thuringiensis, and B. mycoides. Bacillus cereus occurs mainly in immunocompromised patients and is an uncommon cause of osteomyelitis in children and adults, secondary to open trauma or use of intravenous drugs. It is susceptible to chloramphenicol, ciprofloxacin, gentamicin, and vancomycin. To our knowledge, osteomyelitis caused by B. cereus in a pediatric immunocompetent patient has not been reported in the literature.


REFERENCES

  1. Mahon R, Lehman D. Diagnostic microbiology. Maryland, Missouri; 2015.

  2. Mandell GL, Bennett JE, Dolin RM. New York City: Churchill Livingstone; 2016.

  3. Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010; 23: 382.

  4. Fernández-No IC, Böhme K, Díaz-Bao M et al. Characterization and profiling of Bacillus subtilis, Bacillus cereus and Bacillus licheniformis by MALDI-TOF mass fingerprinting. Food Microbiol. 2013; 33: 235.

  5. John S, Neary J, Lee CH. Invasive Bacillus cereus infection in a renal transplant patient: a case report and review. Can J Infect Dis Med Microbiol. 2012; 23: e109.

  6. Luna VA, King DS, Gulledge J et al. Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods. J Antimicrob Chemother. 2007; 60: 555.

  7. Andrews JM, Wise R. Susceptibility testing of Bacillus species. J Antimicrob Chemother. 2002; 49: 1040.

  8. Weber DJ, Saviteer SM, Rutala WA, Thomann CA. In vitro susceptibility of Bacillus spp. to selected antimicrobial agents. Antimicrob Agents Chemother. 1988; 32: 642.

  9. Dryden MS, Kramer JM. Toxigenic Bacillus cereus as a cause of wound infections in the tropics. J Infect. 1987; 15: 207.

  10. Dubouix A, Bonnet E, Alvarez M et al. Bacillus cereus infections in Traumatology-Orthopaedics Department: retrospective investigation and improvement of healthcare practices. J Infect. 2005; 50: 22.

  11. Ribeiro NF, Heath CH, Kierath J et al. Burn wounds infected by contaminated water: case reports, review of the literature and recommendations for treatment. Burns. 2010; 36: 9.

  12. Dartnell J, Ramachandran M, Katchburian M. Haematogenous acute and subacute paediatric osteomyelitis: a systematic review of the literature. J Bone Joint Surg Br. 2012; 94: 584.

  13. Krause A, Freeman R, Sisson PR, Murphy OM. Infection with Bacillus cereus after close-range gunshot injuries. J Trauma. 1996; 41: 546.




2020     |     www.medigraphic.com